Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

CCO Oncology Podcast - En podcast af Clinical Care Options

Prøv Podimo gratis! i 30 dage

Prøv Podimo gratis! i 30 dage

Et univers fyldt med hundredvis af eksklusive podcasts & lydbøger, klik her for at prøve

 Annoncering
Podcast artwork

Kategorier:

Uddannelse

Caitlin Costello, MD, discusses the role and safety of bispecific antibodies approved for the treatment of relapsed/refractory multiple myeloma as well as emerging data and clinical trials with this treatment approach.

Visit the podcast's native language site